• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

3.620 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GlucoTrack, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Glucotrack, Inc. Encourages Shareholders to Vote
November 03, 2025
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
October 29, 2025
Renowned pain management and medical technology leader to accelerate Glucotrack’s strategy for integrated glucose monitoring applications, building on Company’s 2024 expansion into epidural monitoring 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack, Inc. Reminds Shareholders to Vote
October 28, 2025
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
September 30, 2025
Via ACCESS Newswire
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
September 16, 2025
Via ACCESS Newswire
News headline image
Glucotrack to Participate in the Q3 Virtual Investor Summit
September 11, 2025
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
August 06, 2025
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestones 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
July 31, 2025
Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot study 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Announces Repurchase of Series A Warrants
July 08, 2025
Warrant buyback extinguishes warrant liability accounting and share dilution overhang 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
June 25, 2025
Comprehensive analysis confirms safety and strong accuracy of Glucotrack's innovative blood-based continuous glucose monitoring technology, with MARD of 7.7% 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management
June 10, 2025
Via TheNewswire.com
News headline image
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management
June 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
June 04, 2025
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
May 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives
May 29, 2025
Via TheNewswire.com
News headline image
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28, 2025
Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
May 20, 2025
Patients get a seat at the table in development of long-term implantable continuous blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients
May 14, 2025
Via TheNewswire.com
News headline image
First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients
May 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
May 13, 2025
Long-term clinical evaluation represents key advancement following successful first-in-human study 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes study 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
April 03, 2025
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
March 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
March 19, 2025
Via TheNewswire.com
News headline image
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
March 19, 2025
Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conference 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
February 26, 2025
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
February 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
February 25, 2025
By JE Insights, Benzinga 
Via TheNewswire.com
News headline image
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
February 04, 2025
The study met its primary endpoint with no procedure or device related serious adverse events reported 
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Announces Reverse Stock Split
January 30, 2025
1-for-20 reverse stock split to become effective as of the opening of trading on February 4, 2025 
From Glucotrack, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap